Latest Insider Transactions at Hims & Hers Health, Inc. (HIMS)
This section provides a real-time view of insider transactions for Hims & Hers Health, Inc. (HIMS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Hims & Hers Health, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Hims & Hers Health, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 16
2025
|
Andrew Dudum Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
47,534
-4.6%
|
$1,283,418
$27.12 P/Share
|
|
Jan 16
2025
|
Andrew Dudum Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
36,460
-17.43%
|
$984,420
$27.17 P/Share
|
|
Jan 16
2025
|
Andrew Dudum Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
33,668
+34.34%
|
$67,336
$2.43 P/Share
|
|
Jan 13
2025
|
Oluyemi Okupe Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
11,581
-3.03%
|
$277,944
$24.51 P/Share
|
|
Jan 13
2025
|
Oluyemi Okupe Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,437
+4.73%
|
$32,185
$5.01 P/Share
|
|
Jan 10
2025
|
Michael Chi Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
7,259
-3.61%
|
$174,216
$24.07 P/Share
|
|
Jan 10
2025
|
Michael Chi Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,259
+3.49%
|
$43,554
$6.82 P/Share
|
|
Jan 06
2025
|
Soleil Boughton Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
268,932
-34.74%
|
$7,261,164
$27.86 P/Share
|
|
Jan 06
2025
|
Soleil Boughton Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
254,023
+25.91%
|
$762,069
$3.72 P/Share
|
|
Jan 02
2025
|
Oluyemi Okupe Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
11,581
-2.91%
|
$277,944
$24.68 P/Share
|
|
Jan 02
2025
|
Oluyemi Okupe Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,437
+4.56%
|
$32,185
$5.01 P/Share
|
|
Jan 02
2025
|
Michael Chi Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
2,055
-1.05%
|
$49,320
$24.62 P/Share
|
|
Jan 02
2025
|
Michael Chi Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,055
+1.04%
|
$22,605
$11.53 P/Share
|
|
Dec 27
2024
|
Melissa Baird Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
31,518
+2.17%
|
$94,554
$3.72 P/Share
|
|
Dec 26
2024
|
Oluyemi Okupe Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
4,213
-3.18%
|
$122,177
$29.98 P/Share
|
|
Dec 24
2024
|
Michael Chi Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
17,303
-8.2%
|
$467,181
$27.97 P/Share
|
|
Dec 24
2024
|
Michael Chi Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
17,303
+7.58%
|
$86,515
$5.01 P/Share
|
|
Dec 20
2024
|
Oluyemi Okupe Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
18,959
-3.28%
|
$473,975
$25.76 P/Share
|
|
Dec 19
2024
|
Michael Chi Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
7,500
-3.73%
|
$195,000
$26.0 P/Share
|
|
Dec 19
2024
|
Michael Chi Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+3.6%
|
$97,500
$13.9 P/Share
|
|
Dec 17
2024
|
Andrew Dudum Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
79,246
-44.02%
|
$2,535,872
$32.32 P/Share
|
|
Dec 17
2024
|
Irene Becklund PAO |
SELL
Open market or private sale
|
Direct |
10,012
-57.77%
|
$320,384
$32.2 P/Share
|
|
Dec 17
2024
|
Michael Chi Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
25,550
-11.66%
|
$817,600
$32.2 P/Share
|
|
Dec 16
2024
|
Andrew Dudum Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
78,127
-14.13%
|
$2,265,683
$29.2 P/Share
|
|
Dec 16
2024
|
Andrew Dudum Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
75,335
+15.0%
|
$150,670
$2.43 P/Share
|
|
Dec 16
2024
|
Andrew Dudum Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
47,534
-4.25%
|
$1,378,486
$29.34 P/Share
|
|
Dec 16
2024
|
Irene Becklund PAO |
SELL
Open market or private sale
|
Direct |
472
-2.65%
|
$13,688
$29.58 P/Share
|
|
Dec 16
2024
|
Irene Becklund PAO |
BUY
Exercise of conversion of derivative security
|
Direct |
472
+2.58%
|
$4,248
$9.41 P/Share
|
|
Dec 13
2024
|
Andrew Dudum Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
97,062
-46.26%
|
$2,911,860
$30.02 P/Share
|
|
Dec 13
2024
|
Andrew Dudum Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
176,308
+45.66%
|
-
|
|
Dec 13
2024
|
Melissa Baird Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
28,778
-4.09%
|
$863,340
$30.02 P/Share
|
|
Dec 13
2024
|
Melissa Baird Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
73,146
+9.41%
|
-
|
|
Dec 13
2024
|
Oluyemi Okupe Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
51,573
-25.39%
|
$1,547,190
$30.02 P/Share
|
|
Dec 13
2024
|
Oluyemi Okupe Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
93,718
+31.57%
|
-
|
|
Dec 13
2024
|
Soleil Boughton Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
23,751
-11.39%
|
$712,530
$30.02 P/Share
|
|
Dec 13
2024
|
Soleil Boughton Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
43,209
+17.17%
|
-
|
|
Dec 13
2024
|
Patrick Harrison Carroll Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,387
-2.63%
|
$161,610
$30.02 P/Share
|
|
Dec 13
2024
|
Patrick Harrison Carroll Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,988
+5.95%
|
-
|
|
Dec 13
2024
|
Irene Becklund PAO |
SELL
Payment of exercise price or tax liability
|
Direct |
11,875
-40.66%
|
$356,250
$30.02 P/Share
|
|
Dec 13
2024
|
Irene Becklund PAO |
BUY
Exercise of conversion of derivative security
|
Direct |
24,090
+45.2%
|
-
|
|
Dec 13
2024
|
David B Wells Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,046
+5.7%
|
-
|
|
Dec 13
2024
|
Michael Chi Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
42,304
-16.18%
|
$1,269,120
$30.02 P/Share
|
|
Dec 13
2024
|
Michael Chi Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
76,508
+22.64%
|
-
|
|
Dec 10
2024
|
Melissa Baird Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
85,561
-4.12%
|
$2,652,391
$31.21 P/Share
|
|
Dec 10
2024
|
Melissa Baird Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
85,561
+10.67%
|
$0
$0.4 P/Share
|
|
Dec 10
2024
|
Michael Chi Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
7,259
-3.78%
|
$232,288
$32.25 P/Share
|
|
Dec 10
2024
|
Michael Chi Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,259
+3.64%
|
$43,554
$6.82 P/Share
|
|
Dec 02
2024
|
Andrew Dudum Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
33,513
-50.01%
|
$1,105,929
$33.38 P/Share
|
|
Dec 02
2024
|
Michael Chi Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
2,054
-1.1%
|
$67,782
$33.56 P/Share
|
|
Dec 02
2024
|
Michael Chi Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,054
+1.09%
|
$22,594
$11.53 P/Share
|